HER2+ breast cancer treatment and cardiotoxicity: monitoring and management.
Saved in:
| Title: | HER2+ breast cancer treatment and cardiotoxicity: monitoring and management. |
|---|---|
| Authors: | Jerusalem G; Department of Medical Oncology, Centre Hospitalier Universitaire du Sart-Tilman, University of Liege, Liège, Belgium. g.jerusalem@chu.ulg.ac.be., Lancellotti P; GIGA Cardiovascular Sciences, Department of Cardiology, Centre Hospitalier Universitaire du Sart-Tilman, University of Liege, Liège, Belgium., Kim SB; Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea. |
| Source: | Breast cancer research and treatment [Breast Cancer Res Treat] 2019 Sep; Vol. 177 (2), pp. 237-250. Date of Electronic Publication: 2019 Jun 05. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 31165940 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: HER2+ breast cancer treatment and cardiotoxicity: monitoring and management. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Jerusalem+G%22">Jerusalem G</searchLink>; Department of Medical Oncology, Centre Hospitalier Universitaire du Sart-Tilman, University of Liege, Liège, Belgium. g.jerusalem@chu.ulg.ac.be.<br /><searchLink fieldCode="AU" term="%22Lancellotti+P%22">Lancellotti P</searchLink>; GIGA Cardiovascular Sciences, Department of Cardiology, Centre Hospitalier Universitaire du Sart-Tilman, University of Liege, Liège, Belgium.<br /><searchLink fieldCode="AU" term="%22Kim+SB%22">Kim SB</searchLink>; Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228111104%22">Breast cancer research and treatment</searchLink> [Breast Cancer Res Treat] 2019 Sep; Vol. 177 (2), pp. 237-250. <i>Date of Electronic Publication: </i>2019 Jun 05. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Kluwer+Academic%22">Kluwer Academic </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8111104 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-7217 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201676806%22">01676806 </searchLink><i>NLM ISO Abbreviation: </i>Breast Cancer Res Treat <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31165940 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s10549-019-05303-y Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 237 Titles: – TitleFull: HER2+ breast cancer treatment and cardiotoxicity: monitoring and management. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Jerusalem G – PersonEntity: Name: NameFull: Lancellotti P – PersonEntity: Name: NameFull: Kim SB IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2019 Sep Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 1573-7217 Numbering: – Type: volume Value: 177 – Type: issue Value: 2 Titles: – TitleFull: Breast cancer research and treatment Type: main |
| ResultId | 1 |